Showing results (311-320 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|February 27, 2020
Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung CancerSagar O Rohondia, Zainab Sabry Othman Ahmed, Q Ping DouCurrent Cancer Drug Targets|November 9, 2019
circEPSTI1 Acts as a ceRNA to Regulate the Progression of OsteosarcomaXinyu Tan, Duxun Tan, Haomiao Li, et al.Current Cancer Drug Targets|December 10, 2019
PPARγ Agonists in Combination Cancer TherapiesPiotr Mrowka, Eliza Glodkowska-MrowkaCurrent Cancer Drug Targets|November 29, 2014
Interactions of cisplatin with non-DNA targets and their influence on anticancer activity and drug toxicity: the complex world of the platinum complexRoman MezencevCurrent Cancer Drug Targets|March 10, 2018
Role of miR-193a in Cancer: Complexity and Factors Control the Pattern of its ExpressionAfraa Mamoori, Vinod Gopalan, Alfred K-Y LamCurrent Cancer Drug Targets|December 12, 2018
Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung CancerTatsuya Nagano, Motoko Tachihara, Yoshihiro NishimuraCurrent Cancer Drug Targets|May 19, 2022
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic CancerFereshteh Asgharzadeh, Kiarash Roustai Geraylow, Majid Khazaei, et al.Current Cancer Drug Targets|July 21, 2021
The Plasticity of Circulating Tumor Cells in Ovarian Cancer During Platinum-containing ChemotherapySnezhanna Olegovna Gening, Dinara Rishatovna Dolgova, Tatyana Vladimirovna Abakumova, et al.Current Cancer Drug Targets|June 3, 2021
CDK-associated Cullin 1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Human GlioblastomaXiaohua Zhang, Tianying Zhang, Xiaojuan Han, et al.Current Cancer Drug Targets|January 11, 2021
Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic RegulatorsStefanie Rauscher, Richard Greil, Roland GeisbergerPageof 187